drugset / Trial / NCT00237510
Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is based on the hypothesis that terazosin, a blocker of alpha-1 receptors, will be effective in reducing excessive sweating caused by antidepressant treatment, and will have minimal adverse effects.
Timeline
- Start
- 2005-05
- Primary completion
- 2006-05
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Terazosin | Small molecule | — | — |
Indications
No indication recorded.